Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Maastricht Universitair Medisch Centrum
Dutch Colorectal Cancer Group
National Institutes of Health
Wageningen University and Research
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Evaluation of potential biomarkers during irinotecan-based systemic treatment for colorectal cancer—study protocol of the OPTIMA study
Thomas Böhm, Liselot Valkenburg‐van Iersel, Matthew R. Redinbo, Ella M. Russ et al.
Journal
BMC Cancer
Topics
Cancer therapeutics and mechanisms
article
Evaluation of potential biomarkers during irinotecan-based systemic treatment for colorectal cancer—study protocol of the OPTIMA study
Thomas Böhm, Liselot Valkenburg‐van Iersel, Matthew R. Redinbo, Ella M. Russ, H Vestjens, Marjolein Louisa Smidt, A. Goosens, Judith de Vos‐Geelen, Tineke E. Buffart, Lars E. Hillege, John Penders, Janine Ziemons, Clara C. Elbers, Lee C. Vermeulen, Lauri Borghuis, Irene E.G. van Hellemond, Anne-Marie Dietvorst, E.M.G.J. de Jong, Maarten J. Deenen, Sander M. J. van Kuijk, A. Baars, P. Kristen, Leonieke Valk
article en
Abstract
No abstract available for this paper.
Publication Tag
BMC CancerVol. 25(1)
Institutions
University of North Carolina at Chapel Hill (US), Radboud University Nijmegen (NL), Leiden University Medical Center (NL), Maastricht University Medical Centre (NL), Catharina Ziekenhuis (NL), Bethesda Hospital (IN), Maastricht University (NL), Rode Kruis Ziekenhuis (NL), Oncode Institute (NL), VieCuri Medisch Centrum (NL), Ziekenhuis Gelderse Vallei (NL), Amsterdam University Medical Centers (NL), Cancer Center Amsterdam (NL), University of Amsterdam (NL), Wageningen University & Research (NL)
Funders
Danone, Universiteit Maastricht, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Maastricht Universitair Medisch Centrum, Dutch Colorectal Cancer Group, National Institutes of Health, Wageningen University and Research